Managing Director and Head of China Healthcare at General Atlantic. Ph.D from Johns Hopkins University School of Medicine. He has served or current serves as non-executive director of various Healthcare and Life Science companies such as Adagene, OcuMension, CanBridge and Genesis MedTech. He had also led in a USD 200+ million PIPE investment in HutchMed and named as the management advisor. Lefei was once founding partner and a member of the investment committee at Huatai Healthcare Investment Fund, and successfully led strategic investment at Mindray Medical (stock code: 300760) and MIcroPort CardioFlow Medtech (stock code: 02160.HK).